Wen Cheng
Impact in
-
- Cancer-related molecular mechanisms research
-
- Glioma Diagnosis and Treatment
Papers in
-
- RNA modifications and cancer 4
- Surgery 5
- Bladder and Urothelial Cancer Treatments 3
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Jing Lin (6 shared papers)Jinquan Cai (1 shared paper)Yang Liu (1 shared paper)Xiufang Ren (1 shared paper)Sheng Han (1 shared paper)Anhua Wu (1 shared paper)Chuanbao Zhang (1 shared paper)Xingyang Yi (5 shared papers)
- Journals
- Journal of Stroke and Cerebrovascular Diseases (3 papers)Oncotarget (1 paper)Journal of Atherosclerosis and Thrombosis (1 paper)Frontiers in Oncology (1 paper)Neurology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wen Cheng
28 papers receiving 680 citations
Wen Cheng's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 133
- Genetics 71
- Cardiology and Cardiovascular Medicine 124
- Pulmonary and Respiratory Medicine 177
- Internal Medicine 17
Countries citing papers authored by Wen Cheng
This map shows the geographic impact of Wen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Cheng more than expected).
Fields of papers citing papers by Wen Cheng
This network shows the impact of papers produced by Wen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Cheng. The network helps show where Wen Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance Hit paper breakdown → | 2022 | 163 |
| 2 | 2016 | 156 | |
| 3 | 2014 | 46 | |
| 4 | 2016 | 45 | |
| 5 | 2016 | 42 | |
| 6 | 2020 | 30 | |
| 7 | 2013 | 23 | |
| 8 | 2016 | 20 | |
| 9 | 2016 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2016 | 15 | |
| 13 | 2022 | 15 | |
| 14 | 2016 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2015 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2010 | 6 | |
| 20 | 2018 | 5 |
About Wen Cheng
Wen Cheng is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 29 papers that have together received 689 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Pain Mechanisms and Treatments (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Pain Management and Treatment (1 paper) and Acupuncture Treatment Research Studies (1 paper). The work is most often cited by research in Cancer Research (133 citations), Genetics (71 citations), Cardiology and Cardiovascular Medicine (124 citations), Pulmonary and Respiratory Medicine (177 citations) and Internal Medicine (17 citations). Wen Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Jing Lin, Jinquan Cai, Yang Liu, Xiufang Ren, Sheng Han, Anhua Wu, Chuanbao Zhang, Xingyang Yi, Qiang Zhou and Yuhang Wang. Their work appears in journals such as Journal of Stroke and Cerebrovascular Diseases, Oncotarget, Journal of Atherosclerosis and Thrombosis, Frontiers in Oncology and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.